These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 4963814)

  • 1. [Importance of the choice of the method of administration of extracts for the determination of corticotropin-releasing-factor activity].
    Mialhe-Voloss C; Koch B
    C R Acad Hebd Seances Acad Sci D; 1967 Feb; 264(7):953-5. PubMed ID: 4963814
    [No Abstract]   [Full Text] [Related]  

  • 2. [ACTH releasing action of vasopressin].
    Hiroshige T
    Saishin Igaku; 1971 Apr; 26(4):697-705. PubMed ID: 4329833
    [No Abstract]   [Full Text] [Related]  

  • 3. Stimulation of corticotropin release by corticotropin-releasing factor (CRF) or by vasopressin following intrapituitary infusions in unanesthetized dogs: inhibition of the responses by dexamethasone.
    Gonzalez-Luque A; L'age M; Dhariwal AP; Yates FE
    Endocrinology; 1970 May; 86(5):1134-42. PubMed ID: 4314067
    [No Abstract]   [Full Text] [Related]  

  • 4. Evidence for the presence of tumor peptides with corticotropin-releasing-factor-like activity in the ectopic ACTH syndrome.
    Upton GV; Amatruda TT
    N Engl J Med; 1971 Aug; 285(8):419-24. PubMed ID: 4326719
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies of the changes in adrenal corticosterone in mice treated with dexamethasone, chlorpromazine, morphine and codeine: development of an assay for corticotrophin-releasing factor.
    Cheifetz PN
    Acta Endocrinol (Copenh); 1972 May; 70(1):56-64. PubMed ID: 4338050
    [No Abstract]   [Full Text] [Related]  

  • 6. On the corticotropin releasing activity of antidiuretic hormone.
    Tanaka A; Furukawa T; Odaguti K
    Med J Osaka Univ; 1971 Mar; 21(2):181-7. PubMed ID: 4334603
    [No Abstract]   [Full Text] [Related]  

  • 7. [Studies on the mechanism of ACTH-secretion with special reference to the bioassay of C.R.F. in vitro].
    Nakai Y
    Nihon Naibunpi Gakkai Zasshi; 1968 Jan; 43(10):957-76. PubMed ID: 4298016
    [No Abstract]   [Full Text] [Related]  

  • 8. Carotid or jugular amino acid infusions and food intake in the cockerel.
    Tobin G; Boorman KN
    Br J Nutr; 1979 Jan; 41(1):157-62. PubMed ID: 420748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical studies on the adrenocorticotropic hormone. II. Studies on the mechanism of pituitary corticotropin secretion with synthetic lysine vasopressin].
    Mayama T
    Nihon Naibunpi Gakkai Zasshi; 1968 Jan; 43(10):947-56. PubMed ID: 4298936
    [No Abstract]   [Full Text] [Related]  

  • 10. Potentiation by vasopressin of corticotropin release induced by corticotropin-releasing factor.
    Yates FE; Russell SM; Dallman MF; Hodge GA; McCann SM; Dhariwal AP
    Endocrinology; 1971 Jan; 88(1):3-15. PubMed ID: 4320769
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of lysine vasopressin and hypothalamic extracts on the rate of corticosterone secretion in rats treated with dexamethasone and pentobarbitone.
    Cheifetz PN; Gaffud NT; Dingman JF
    J Endocrinol; 1969 Apr; 43(4):521-8. PubMed ID: 4305768
    [No Abstract]   [Full Text] [Related]  

  • 12. Dissociation between production and storage of corticotrophin-releasing factor.
    Smelik PG; Hedge GA
    J Endocrinol; 1969 Jan; 43(1):xxxvii. PubMed ID: 4307044
    [No Abstract]   [Full Text] [Related]  

  • 13. Corticotropin releasing activity of lysine vasopressin analogues.
    Arimura A; Schally AV; Bowers CY
    Endocrinology; 1969 Mar; 84(3):579-83. PubMed ID: 5304758
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of assays for corticotrophin-releasing activity.
    Chan LT; de Wied D; Saffran M
    Endocrinology; 1969 Apr; 84(4):967-72. PubMed ID: 4304035
    [No Abstract]   [Full Text] [Related]  

  • 15. Assays for corticotropin-releasing factor (CRF) using rats treated with morphine, chlorpromazine, dexamethasone and Nembutal.
    Arimura A; Saito T; Schally AV
    Endocrinology; 1967 Aug; 81(2):235-45. PubMed ID: 4951998
    [No Abstract]   [Full Text] [Related]  

  • 16. Corticotropin-releasing factor.
    Yasuda N; Greer MA; Aizawa T
    Endocr Rev; 1982; 3(2):123-40. PubMed ID: 6282576
    [No Abstract]   [Full Text] [Related]  

  • 17. The action of dexamethasone and vasopressin on hypothalamic CRF production and release.
    Hedge GA; Smelik PG
    Neuroendocrinology; 1969; 4(4):242-53. PubMed ID: 4894214
    [No Abstract]   [Full Text] [Related]  

  • 18. DIFFERENCE BETWEEN THE BLOOD PRESSURE RESPONSES TO INTRAJUGULAR AND INTRACAROTID INJECTIONS PHYSOSTIGMINE, AND THE SYNDROME OF CONTRALATERAL TORSION IN THE RAT.
    KRSTIC M; VARAGIC V
    Br J Pharmacol Chemother; 1965 Feb; 24(1):132-7. PubMed ID: 14301991
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of a CRF preparation on ACTH release in rats bearing hypothalamic dexamethasone implants: a study on the "implantation paradox".
    Smelik PG
    Neuroendocrinology; 1969; 5(3):193-204. PubMed ID: 4312009
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies on the site of action of vasopressin in inducing adrenocorticotropin secretion.
    Yasuda N; Greer MA; Greer SE; Panton P
    Endocrinology; 1978 Sep; 103(3):906-11. PubMed ID: 217660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.